Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Роль самоконтроля гликемии в снижении риска развития диабетических микро- и макроангиопатий
________________________________________________
Batrak G.A., Miasoedova S.E., Brodovskaia A.N. The role of glycemia self-control in decrease of the risk of diabetic micro- and macroangiopathies. Consilium Medicum. 2019; 21 (12): 55–58. DOI: 10.26442/20751753.2019.12.190631
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
________________________________________________
2. Auni G et al. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 2008; 31 (4): 714–9.
3. Rückert IM et al. Blood pressure and lipid management fall far short in persons with type 2diabetes: Results from the DIAB-CORE Consortium including six German population-based studies. Cardiovasc Diabetol 2012; 8, 11 (1): 50.
4. Pitocco D et al. Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud 2010; 7 (1): 15–25.
5. Kitasato L et al. Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide. Cardiovasc Diabetol 2012; 29 (11; 1): 79.
6. Radermecker RP et al. Blood glucose control and cardiovascular disease in patiens with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials. Rev Med Liege 2008; 63 (7–8). 511–8.
7. Ginsberg HN et al. Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus. The Action to Control Cardiovascular Risk in Diabetes (ACCORD Study Group). N Engl J Med 2010; 18.
8. Fuchtenbusch M, Hummel M. Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study, MMW. Fortschr Med 2008; 24 (150, 17): 42–4.
9. Cefalu WT, Watson K, Cefalu WT. Intensive glycemic control and cardiovascular disease. Observations from the ACCORD study. Diabetes 2008; 57: 1163–5.
10. Patel A et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
11. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 9-й вып. М., 2019.
[Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom Pod red. I.I. Dedova, M.V. Shestakovoi, A.Iu. Maiorova. 9-i vyp. Moscow, 2019. (in Russian).]
12. Duckworth W et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39.
13. Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med 2008; 358 (24): 2630–3.
14. Бродовская А.Н., Батрак Г.А. Взаимосвязь вариабельности гликемии и поражения почек у больных с впервые выявленным сахарным диабетом 2 типа. Вестн. Ивановской медицинской академии. 2018; 23 (2): 48–9.
[Brodovskaia A.N., Batrak G.A. Vzaimosviaz' variabel'nosti glikemii i porazheniia pochek u bol'nykh s vpervye vyiavlennym sakharnym diabetom 2 tipa. Vestn. Ivanovskoi meditsinskoi akademii. 2018; 23 (2): 48–9 (in Russian).]
16. Bailey T et al. Diabetes Sci and Technol 2017; 11 (4): 736-43.
________________________________________________
3. Rückert IM et al. Blood pressure and lipid management fall far short in persons with type 2diabe-tes: Results from the DIAB-CORE Consortium including six German population-based studies. Cardiovasc Diabetol 2012; 8, 11 (1): 50.
9. Cefalu WT, Watson K, Cefalu WT. Intensive glycemic control and cardiovascular disease. Obser-vations from the ACCORD study. Diabetes 2008; 57: 1163–5.
10. Patel A et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabe-tes. N Engl J Med 2008; 358: 2560–72.
Г.А. Батрак*1, С.Е. Мясоедова1, А.Н. Бродовская2
1 ФГБОУ ВО «Ивановская государственная медицинская академия» Минздрава России, Иваново, Россия;
2 ОБУЗ «Городская клиническая больница №4», Иваново, Россия
________________________________________________
*gbatrak@mail.ru